Ionis Pharmaceuticals Inc. Common Stock vs Vicor Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Vicor Corporation Common Stock trades at $232.89 (market cap $11.31B). The key difference: Vicor Corporation Common Stock is the larger of the two by market cap, and Vicor Corporation Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.
| IONS | VICR | |
|---|---|---|
Market Cap | $7.10B | $11.31B |
Volume | 2,027,457 | 809,713 |
Sector | Health | Technology |
52-Week High | $86.50 | $379.78 |
52-Week Low | $42.38 | $57.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.66B | $10.87B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →